Compare HCA Health Inc (HCA) vs Zeta Global Holdings Corp (ZETA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Zeta Global Holdings Corp — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Zeta Global Holdings Corp trades at $33.09 (market cap $8.29B). The key difference: HCA Health Inc is far larger — about 11.6× Zeta Global Holdings Corp's market cap, and HCA Health Inc pays a 0.7% dividend while Zeta Global Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Zeta Global Holdings Corp for 19 Days on average.
| HCA | ZETA | |
|---|---|---|
Market Cap | $96.35B | $8.29B |
Volume | 1,079,453 | 7,156,795 |
Sector | Health | Technology |
52-Week High | $545.13 | $33.74 |
52-Week Low | $361.32 | $14.55 |
Typical Hold Time | 76 Days | 19 Days |
Enterprise Value | $146.88B | $8.18B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
ZETA trades at $33.03, down 2.1% today but remains near recent highs with strong technical momentum. The company shows robust revenue growth with $1.3B in 2025 and projected $1.6B in 2026, though profitability remains challenged with negative net margins. Recent earnings beats and expanding customer base (197 superscale customers in Q2 2026) support the bullish analyst consensus.
ZETA presents a growth story with expanding AI platform adoption and international expansion, but faces execution risks amid negative cash flow and high valuation multiples. The stock's 75% buy rating from analysts suggests upside potential, though investors should monitor margin improvement and cash flow sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Zeta Global Holdings Corp
Zeta Global is a leading data-driven marketing technology company that provides an omnichannel AI Marketing Cloud. By leveraging a proprietary data cloud of over 2.4 billion deterministic identities, it enables enterprise brands to acquire, grow, and retain customers through predictive intelligence and automated, agentic workflows.
Read more on ZETA →
